List of medicines under additional monitoring European Medicines Agency
Even so, an October 2025 Gallup poll reported that 12.4% of respondents to a nationally representative survey were taking this class of medication for weight loss
Full AI Image Prompt: Create a clean medical infographic titled GHK-Cu Claim Strength Matrix. Use a two-axis matrix with the horizontal axis labeled Evidence strength and the vertical axis labeled Claim scope. Place labeled cards: Topical skin aging, Wound-care context, Hair growth, Injectable regeneration, and Systemic anti-aging. Position topical skin aging and wound-care context closer to stronger evidence, hair growth in a limited or indirect evidence area, and injectable regeneration and systemic anti-aging in an uncertain evidence-gap area
In addition, elevated levels of cell adhesion molecules (ICAM-1, VCAM-1, SELL, ITGB1, and ITGB2), NADPH oxidase activity, and inflammatory cytokines (MCP-1 and TNF) were observed in G6PD-deficient cells [10, 11] (Fig